TC BioPharm (Holdings) PLC (TCBP)
0.61
-0.04
(-5.99%)
USD |
NASDAQ |
Nov 15, 15:35
TC BioPharm Net Income (TTM)
Net Income (TTM) Chart
Historical Net Income (TTM) Data
Date | Value |
---|---|
March 31, 2024 | -9.005M |
June 30, 2023 | -14.48M |
Date | Value |
---|---|
March 31, 2023 | -17.46M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-17.46M
Minimum
Mar 2023
-9.005M
Maximum
Mar 2024
-13.65M
Average
-14.48M
Median
Jun 2023
Net Income (TTM) Benchmarks
Adaptimmune Therapeutics PLC | -72.50M |
Biodexa Pharmaceuticals PLC | -8.534M |
Verona Pharma PLC | -153.72M |
NuCana PLC | -35.48M |
Autolus Therapeutics PLC | -233.98M |